logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Ceftazidime CAS 78439-06-2 White To Cream-Colored Crystalline Powder

Ceftazidime CAS 78439-06-2 White To Cream-Colored Crystalline Powder

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 78439-06-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: D/A,L/C,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

Ceftazidime CAS 78439-06-2

,

Ceftazidime

CAS NO::
78439-06-2
Appearance::
White To Cream-colored Crystalline Powder
Molecular Formula::
C22H22N6O7S2
Molecular Weight::
546.57600
EINECS NO::
276-715-9
MDL NO::
MFCD00153936
CAS NO::
78439-06-2
Appearance::
White To Cream-colored Crystalline Powder
Molecular Formula::
C22H22N6O7S2
Molecular Weight::
546.57600
EINECS NO::
276-715-9
MDL NO::
MFCD00153936
Ceftazidime CAS 78439-06-2 White To Cream-Colored Crystalline Powder

Product Description:

Product Name: Ceftazidime CAS NO: 78439-06-2


Synonyms:

1-[[(6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino] acetyl] amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-en-3-yl]methyl]pyridinum hydroxide inner salt;

(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate;


Chemical & Physical Properties:

Appearance: White to cream-colored crystalline powder

Assay :≥99.00%

Melting Point: >150℃(dec.)

Storage Condition: 2-8℃

Solubility: Sparingly soluble in aqueous solution


Safety Information:

Safety Statements: S22; S36/37; S45; S37; S24

HS Code: 2941905990

Risk Statements: R42/43

Hazard Code: Xn

WGK Germany: 1


Third generation cephalosporin antibiotic. Antibacterial. Ceftazidime is the latest third generation cephalosporin to reach the market. It has one of the broadest spectrums of the cephalosporins, similar in many regards to that of cefotaxime. It is particularly active against Pseudomonas aeruginosa, being perhaps 4-5 times more potent in vitro than moxalactam and cefotaxime.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.